Aptamer-based NIR II imaging for breast cancer surgical resection

Abstract The accuracy of intraoperative tumor margin assessment is the main challenge in breast conserving surgery (BCS). NIR-II fluorescence-guided surgery enables surgeons to visualize the tumor margins dynamically in real time and facilitate the precision of tumor resection. We develop an aptamer...

Full description

Saved in:
Bibliographic Details
Main Authors: Lei Niu, Kang-Liang Lou, Zhi Zhu, Wei-Zhi Liu, Wen-Liang Gao, Gu-Yue Hu, Jun-Xue Gao, Guo-Jun Zhang, Wen-He Huang
Format: Article
Language:English
Published: Nature Portfolio 2025-08-01
Series:npj Imaging
Online Access:https://doi.org/10.1038/s44303-025-00095-x
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849226011333361664
author Lei Niu
Kang-Liang Lou
Zhi Zhu
Wei-Zhi Liu
Wen-Liang Gao
Gu-Yue Hu
Jun-Xue Gao
Guo-Jun Zhang
Wen-He Huang
author_facet Lei Niu
Kang-Liang Lou
Zhi Zhu
Wei-Zhi Liu
Wen-Liang Gao
Gu-Yue Hu
Jun-Xue Gao
Guo-Jun Zhang
Wen-He Huang
author_sort Lei Niu
collection DOAJ
description Abstract The accuracy of intraoperative tumor margin assessment is the main challenge in breast conserving surgery (BCS). NIR-II fluorescence-guided surgery enables surgeons to visualize the tumor margins dynamically in real time and facilitate the precision of tumor resection. We develop an aptamer-conjugated NIR-II probe for intraoperative fluorescence imaging. Peglated indocyanine green (PEG-ICG) was conjugated with an aptamer SYL3C binding to EpCAM to synthesize the probe SYL3C-ICG. Human breast cancer cell lines with different expression levels of EpCAM were employed to assess its tumor-targeting capability. Tumor xenograft models were established to investigate the in vivo selectivity of SYL3C-ICG, and a segmental excision procedure was employed to evaluate the efficacy of the probe in navigating precise surgical resection under NIR-II imaging. In vitro and in vivo fluorescence imaging revealed that NIR-II provides superior imaging resolution and penetration depth compared to NIR-I, and SYL3C-ICG could selectively accumulate at the tumor site, which helps surgeons detect tiny residual malignant lesions invisible to the naked eye and reduce the postoperative recurrence rate.
format Article
id doaj-art-b4b17d3e01bd49779611b907dc1be6fc
institution Kabale University
issn 2948-197X
language English
publishDate 2025-08-01
publisher Nature Portfolio
record_format Article
series npj Imaging
spelling doaj-art-b4b17d3e01bd49779611b907dc1be6fc2025-08-24T11:45:44ZengNature Portfolionpj Imaging2948-197X2025-08-013111010.1038/s44303-025-00095-xAptamer-based NIR II imaging for breast cancer surgical resectionLei Niu0Kang-Liang Lou1Zhi Zhu2Wei-Zhi Liu3Wen-Liang Gao4Gu-Yue Hu5Jun-Xue Gao6Guo-Jun Zhang7Wen-He Huang8Cancer Center and Department of Breast and Thyroid Surgery, Xiang’an Hospital of Xiamen University, School of Medicine, Xiamen UniversityCancer Center and Department of Breast and Thyroid Surgery, Xiang’an Hospital of Xiamen University, School of Medicine, Xiamen UniversityKey Laboratory for Chemical Biology of Fujian ProvinceKey Laboratory for Chemical Biology of Fujian ProvinceCancer Center and Department of Breast and Thyroid Surgery, Xiang’an Hospital of Xiamen University, School of Medicine, Xiamen UniversityDepartment of Ultrasound, Xiang’an Hospital of Xiamen University, School of Medicine, Xiamen UniversityDepartment of Ultrasound, Xiang’an Hospital of Xiamen University, School of Medicine, Xiamen UniversityCancer Center and Department of Breast and Thyroid Surgery, Xiang’an Hospital of Xiamen University, School of Medicine, Xiamen UniversityCancer Center and Department of Breast and Thyroid Surgery, Xiang’an Hospital of Xiamen University, School of Medicine, Xiamen UniversityAbstract The accuracy of intraoperative tumor margin assessment is the main challenge in breast conserving surgery (BCS). NIR-II fluorescence-guided surgery enables surgeons to visualize the tumor margins dynamically in real time and facilitate the precision of tumor resection. We develop an aptamer-conjugated NIR-II probe for intraoperative fluorescence imaging. Peglated indocyanine green (PEG-ICG) was conjugated with an aptamer SYL3C binding to EpCAM to synthesize the probe SYL3C-ICG. Human breast cancer cell lines with different expression levels of EpCAM were employed to assess its tumor-targeting capability. Tumor xenograft models were established to investigate the in vivo selectivity of SYL3C-ICG, and a segmental excision procedure was employed to evaluate the efficacy of the probe in navigating precise surgical resection under NIR-II imaging. In vitro and in vivo fluorescence imaging revealed that NIR-II provides superior imaging resolution and penetration depth compared to NIR-I, and SYL3C-ICG could selectively accumulate at the tumor site, which helps surgeons detect tiny residual malignant lesions invisible to the naked eye and reduce the postoperative recurrence rate.https://doi.org/10.1038/s44303-025-00095-x
spellingShingle Lei Niu
Kang-Liang Lou
Zhi Zhu
Wei-Zhi Liu
Wen-Liang Gao
Gu-Yue Hu
Jun-Xue Gao
Guo-Jun Zhang
Wen-He Huang
Aptamer-based NIR II imaging for breast cancer surgical resection
npj Imaging
title Aptamer-based NIR II imaging for breast cancer surgical resection
title_full Aptamer-based NIR II imaging for breast cancer surgical resection
title_fullStr Aptamer-based NIR II imaging for breast cancer surgical resection
title_full_unstemmed Aptamer-based NIR II imaging for breast cancer surgical resection
title_short Aptamer-based NIR II imaging for breast cancer surgical resection
title_sort aptamer based nir ii imaging for breast cancer surgical resection
url https://doi.org/10.1038/s44303-025-00095-x
work_keys_str_mv AT leiniu aptamerbasedniriiimagingforbreastcancersurgicalresection
AT kanglianglou aptamerbasedniriiimagingforbreastcancersurgicalresection
AT zhizhu aptamerbasedniriiimagingforbreastcancersurgicalresection
AT weizhiliu aptamerbasedniriiimagingforbreastcancersurgicalresection
AT wenlianggao aptamerbasedniriiimagingforbreastcancersurgicalresection
AT guyuehu aptamerbasedniriiimagingforbreastcancersurgicalresection
AT junxuegao aptamerbasedniriiimagingforbreastcancersurgicalresection
AT guojunzhang aptamerbasedniriiimagingforbreastcancersurgicalresection
AT wenhehuang aptamerbasedniriiimagingforbreastcancersurgicalresection